about
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists o...
Read More
2.35
0.06
(2.62%)
265.8K
XNYS Volume
XNYS 08 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Annovis Bio Inc is on 10 Sep 2025 for the purpose of Annovis Bio, Inc. H.C. Wainwright 27th Annual Global Investment Conference 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Annovis Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..